# Commission Implementing Regulation (EU) 2018/721 of 16 May 2018 amending Regulation (EU) No 37/2010 to classify the substance porcine prolactin as regards its maximum residue limit (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

In Table 1 of the Annex to Regulation (EU) No 37/2010, an entry for the following substance is inserted in alphabetical order:
Pharmacologically active Substance
Marker residue
Animal Species
MRL
Target Tissues
Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)
Therapeutic Classification
‘Porcine prolactin
NOT APPLICABLE
Porcine
No MRL required
NOT APPLICABLE
For oral use in newborn piglets at a dose of up to 0,2 mg/animal.
For use in sows at a total dose of up to 5 mg/animal.
Agents acting on the reproductive system’

---
Source: https://www.legislation.gov.uk/eur/2018/721/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2018-721/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.